BLOC1S1 and diabetic kidney disease: GCN5L1 was found to aggravate oxidative stress-induced kidney injury by mediating MnSOD acetylation, indicating that GCN5L1 may be a potential intervention target for the treatment of DKD (Lv et al., 2021).